- Home
- CRBP vs PESI Comparison
CRBP vs PESI Comparison
Compare CRBP & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PESI
- Stock Information
- Founded
- CRBP 2009
- PESI 1990
- Country
- CRBP United States
- PESI United States
- Employees
- CRBP N/A
- PESI N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PESI Environmental Services
- Sector
- CRBP Health Care
- PESI Industrials
- Exchange
- CRBP Nasdaq
- PESI Nasdaq
- Market Cap
- CRBP 210.8M
- PESI 231.8M
- IPO Year
- CRBP N/A
- PESI 1992
- Fundamental
- Price
- CRBP $11.23
- PESI $11.97
- Analyst Decision
- CRBP Strong Buy
- PESI
- Analyst Count
- CRBP 9
- PESI 0
- Target Price
- CRBP $48.38
- PESI N/A
- AVG Volume (30 Days)
- CRBP 546.2K
- PESI 215.5K
- Earning Date
- CRBP 11-12-2025
- PESI 11-10-2025
- Dividend Yield
- CRBP N/A
- PESI N/A
- EPS Growth
- CRBP N/A
- PESI N/A
- EPS
- CRBP N/A
- PESI N/A
- Revenue
- CRBP N/A
- PESI $60,661,000.00
- Revenue This Year
- CRBP N/A
- PESI $8.35
- Revenue Next Year
- CRBP $220.00
- PESI $82.81
- P/E Ratio
- CRBP N/A
- PESI N/A
- Revenue Growth
- CRBP N/A
- PESI N/A
- 52 Week Low
- CRBP $4.64
- PESI $6.25
- 52 Week High
- CRBP $20.56
- PESI $16.50
- Technical
- Relative Strength Index (RSI)
- CRBP 38.90
- PESI 47.41
- Support Level
- CRBP $10.88
- PESI $11.21
- Resistance Level
- CRBP $12.43
- PESI $12.50
- Average True Range (ATR)
- CRBP 0.76
- PESI 0.99
- MACD
- CRBP 0.05
- PESI -0.25
- Stochastic Oscillator
- CRBP 51.59
- PESI 19.28
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.